Wuppertal, Germany

Tobias Marquardt

USPTO Granted Patents = 20 

 

 

Average Co-Inventor Count = 7.6

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Berlin, DE (2014 - 2016)
  • Wuppertal, DE (2016 - 2022)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):

Title: The Innovative Work of Inventor Tobias Marquardt

Introduction: Tobias Marquardt, a prominent inventor based in Wuppertal, Germany, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 18 patents, he has focused primarily on developing novel compounds for the treatment and prevention of various cardiovascular and renal disorders.

Latest Patents: Among his recent innovations are the "7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides," which relate to new carboxamides and their application in creating medicaments aimed at cardiovascular and renal disease treatment. Another noteworthy patent involves "Stimulators and/or activators of soluble guanylate cyclase (sGC)" combined with an inhibitor of neutral endopeptidase and/or angiotensin AII antagonists. This invention targets multiple disorders, including chronic kidney failure and various other health complications, demonstrating Marquardt's commitment to advancing medical treatments.

Career Highlights: Marquardt has garnered extensive experience working with leading pharmaceutical companies. He has been associated with Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft, where he has further developed his expertise in medicinal chemistry and pharmacology. His contributions have not only added value to his employers but have also pushed the boundaries of pharmaceutical innovation.

Collaborations: Throughout his career, Marquardt has worked alongside skilled professionals such as Alexandros Vakalopoulos and Johannes-Peter Stasch. These collaborations have played a vital role in enhancing the depth and impact of his research, fostering an environment of innovation and creativity.

Conclusion: Tobias Marquardt is a distinguished inventor whose work in the pharmaceutical field has led to significant advancements in treatments for cardiovascular and renal disorders. His dedication to innovation, coupled with valuable collaborations, highlights his influence as an inventor in the industry. As he continues to pursue new discoveries, Marquardt remains a vital figure in the landscape of medical research and patent development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…